Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

Clinical trial NCT00229697 · COMPLETED

Trial details

NCT number: NCT00229697
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2003-10-01
Primary completion: 2006-12-01
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.